1. PUBLICATION LIST
Name: Gréta Tarlós Pharm D.
E-mail: greta.tarlos@gmail.com
Phone: +3630/5282645
Date: 03/08/2016
Impact factor of published papers: 6.066
Impact factor of citable abstracts: 8.719
Cumulative impact factor: 14.785
Published in international journal:
1. Sipeky C, Weber A, Melegh BI, Matyas P, Janicsek I, Szalai R, Szabo I, Varnai R,
Tarlos G, Ganczer A, Melegh B. Interethnic variability of CYP4F2 (V433M) in
admixed population of Roma and Hungarians. 4. Environ Toxicol Pharmacol. 2015
Jul;40(1):280-3. IF: 2.084
2. Sipeky C, Matyas P, Melegh M, Janicsek I, Szalai R, Szabo I, Varnai R, Tarlos G,
Ganczer A, Melegh B. Lower carrier rate of GJB2 W24X ancestral Indian mutation in
Roma samples from Hungary: implication for public health intervention. Mol Biol
Rep. 2014 Sep;41(9):6105-10. IF: 2.024
3. Sipeky C, Weber A, Szabo M, Melegh BI, Janicsek I, Tarlos G, Szabo I, Sumegi K,
Melegh B. High prevalence of CYP2C19*2 allele in Roma samples: study on Roma
and Hungarian population samples with review of the literature. Mol Biol Rep. 2013
Aug;40(8):4727-35. IF: 1.958
4. Sipeky C, Maász A, Tarlós G, Komlósi K, Pollák É, Melegh B. Significance of
thiopurine s-methyltransferase gene test in a clinical case. Orv Hetil. 2012 Feb
5;153(5):191-4. Hungarian. Indexed in: PubMed, Scopus, Embase, BIOSIS Previews,
Science Citation, Index Expanded, Google Scholar
Submitted to publication, under the consideration:
5. Varnai R, Sipeky C, Melegh BI, Sumegi K, Janicsek I, Szabo I, Duga B, Tarlos G,
Ganczer A, Nagy L, Melegh B. Impact of CYP2C9 and VKORC1 genetic variants on

2. therapeutic dosing of acenocoumarol in Hungarian patients. Manuscript Number:
MOLE-D-14-00536
6. Sipeky C, Maasz A, Tarlos G, Weber A, Csongei V, Melegh B. Unique prevalence of
thiopurine S-methyltransferase (TPMT) gene mutation among Roma population in
Hungary. Mol Biol Rep
Convention abstracts:
7. Sipeky C, Melegh BI, Janicsek I, Duga B, Tarlos G, Szabó I, Jaromi L, Magyari L,
Komlosi K, Hadzsiev K, Melegh B. Pharmacogenetic variations of the SLCO1B1
gene in Roma and Hungarian population samples. Eur J Hum Genet 2012, 20 Suppl. 1,
259. IF: 4.319
8. Sipeky C, Maasz A, Saghy E, Tarlos G, Szabo M, Takacs I, Melegh B.
Polymorphisms of thiopurine S-methyltransferase (TPMT) gene in the average Roma
and Hungarian population samples Eur J Hum Genet 2011,19 Suppl. 2, 344. IF: 4.400
Citable convention abstracts:
9. Sipeky C, Varnai R, Melegh BI, Janicsek I, Szabo I, Duga B, Tarlos G, Melegh B.
Evaluation of cytochrome P450 2C9 and vitamin K epoxide reductase polymorphisms
effecting the anticoagulant response to acenocoumarol in Hungarian patients. 6th
Santorini Conference Biologie Prospective 2012 Systems Biology and Personalized
Health Science and Translation Santorini Island, Greece, 30.09 – 02.10.2012. Drug
Metabolism and Drug Interactions (ISSN: 2191-0162) Issue 3, pp. 121-182.
10. Sipeky C, Varnai R, Melegh BI, Janicsek I, Szabo I, Tarlos G, Nagy L, Melegh B.
Role of CYP2C9 and VKORC1 genetic variants in genotype guided dosing of
acenocoumarol in Hungarian patients. 09-14 June 2014: 2nd ESPT Summer school,
Rome, Italy
11. Varnai R, Sipeky C, Melegh BI, Sumegi K, Janicsek I, Szabo I, Duga B, Tarlos G,
Ganczer A, Nagy L, Melegh B: How the VKORC1 and CYP2C9 genetic
polymorphism influence the effect of acenocoumarol? 12th Congress of Research
Organization of Hungarian Family Physicians, Mórahalom, 22-23. February 2013.
12. Sipeky C, Tarlós G, Janicsek I, Melegh B. SLCO1B1 gene investigation in gipsy and
hungarian populations and this importance of diagnostic in statin therapy. IX.
Convention of Hungarian Humangenetics Company , 23-25 August 2012. Szeged